SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is facing intense scrutiny as investors debate whether current semiconductor demand and AI-driven growth justify recent valuation shifts. While some community members highlight strong fundamental outlooks and long-term infrastructure potential, others are actively tracking short positions and market volatility as potential signs of an overextended sector.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Georgetown, TX.

TSS Inc

TSS Inc. is facing intense community scrutiny and downward price pressure following a weak earnings report that showed significant revenue decline, fueling investor frustration over the company's heavy reliance on Dell and its inability to capitalize on the AI infrastructure boom. While some bulls argue the pivot toward higher-margin systems integration represents a long-term strategic transformation, critics are dismissing the stock as a 'value trap' due to persistent execution concerns and lack of growth.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is rallying as investors turn bullish on its strategic pivot into agentic AI orchestration and software sector recovery, with the community closely tracking high short interest as a potential catalyst for a sustained squeeze. The stock's recent price appreciation, fueled by institutional accumulation and improved fundamentals, has shifted sentiment from bearish skepticism to optimism for long-term growth as market participants look ahead to upcoming earnings.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending following a bullish technical breakout above key resistance levels, with investors actively discussing potential institutional accumulation ahead of upcoming BLA filing milestones. Community sentiment remains focused on the company's clear clinical progress, manufacturing alignment with the FDA, and speculative interest surrounding a major sector buyout.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending as investors digest the impact of recent acquisitions, with the community actively debating whether the company's long-term turnaround strategy justifies its current price action amid lack of formal earnings calls. While some participants are wary of dilution and poor sentiment, others view the stock as a deeply undervalued, long-term opportunity driven by strong institutional backing and a seasoned leadership team.

Workday, Inc. engages in the development of enterprise cloud applications for finance and human resources. The firm delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. It operates through the Cloud Applications segment. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday stock is seeing a massive surge as investors react to reports that private equity giant Silver Lake is exploring a potential acquisition of the company. The community is actively debating the credibility and valuation of these buyout rumors, with many traders questioning the likelihood of a deal while others highlight the resulting upward pressure on the broader software sector.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is facing downward pressure amid investor uncertainty following the announcement of a leadership transition in the CFO role and a subsequent analyst downgrade, despite the company's strong recent earnings and newly authorized share repurchase program. The community remains divided between those viewing the price dip as a strategic long-term buying opportunity given the firm's rapid expansion and fintech dominance, and those frustrated by the stock's persistent lack of upward momentum.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing significant volatility driven by the upcoming August 14 lockup expiration, which has sparked intense debate among the community regarding its fair value versus its current premium to NAV. Investors are closely monitoring the fund's heavy exposure to private AI and aerospace giants like Anthropic and SpaceX, leading to active discussions about whether the current price represents a long-term accumulation opportunity or a continuing 'pump and dump' correction.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is trending as investors weigh significant legislative developments surrounding the Clarity Act against new institutional partnerships, including a strategic IBM patent acquisition. The stock is seeing heightened volatility and accumulation as the community debates whether the upcoming earnings report and potential regulatory breakthroughs will trigger a sustained breakout or if broader market pressures will force a retest of lower support levels.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

SPRY is trending as investors monitor ongoing institutional positioning and short interest dynamics while awaiting news regarding CVS Caremark formulary inclusion. The community remains divided, with debates centered on whether recent volatility reflects a buying opportunity ahead of potential catalysts or broader concerns over the company's commercial execution and competitive landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alico (ALCO) Surpasses Q3 Earnings and Revenue Estimates

Alico (ALCO) delivered earnings and revenue surprises of +139.73% and +247.69%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Archer Daniels Midland (ADM) Q2 Earnings and Revenues Top Estimates

ADM (ADM) delivered earnings and revenue surprises of +29.58% and +1.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

FMC (FMC) Tops Q2 Earnings Estimates

FMC (FMC) delivered earnings and revenue surprises of +23.81% and -7.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Cibus (CBUS) Welcomes Landmark EU Crop Breeding Decision

Cibus (CBUS) Welcomes Landmark EU Crop Breeding Decision...

Cibus (CBUS) Q1 2026 Earnings Transcript

Cibus (CBUS) Q1 2026 Earnings Transcript...

Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates

Cibus (CBUS) delivered earnings and revenue surprises of +5.71% and +29.31%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Bioceres Crop (BIOX) Reports Q3 Loss, Misses Revenue Estimates

Bioceres Crop (BIOX) delivered earnings and revenue surprises of -220.00% and -29.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock?

Cibus (CBUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Cibus, Inc. (NASDAQ:CBUS) Sees Large Growth in Short Interest

Cibus, Inc. (NASDAQ:CBUS - Get Free Report) was the target of a large increase in short interest during the month of April. As of April 15th, there was short interest totaling 4,106,540 shares, an...

Cibus (CBUS) to Release Earnings on Thursday

Cibus (NASDAQ:CBUS) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-cibus-inc-stock...

$CBUS Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.33 up 75.37% YoY
• Reported revenue of $1.68M up 62.57% YoY
• Cibus is on track to deliver annual net cash usage of approximately $30M or less in 2026, and expects existing cash to fund planned operations into late Q1 2027.

https://files.quartr.com/streams/2026-08-13/49529d46-e298-409c-ae39-f8575bb70128/1/live_transcript.jsonl?ref=U3RvY2t0d2l0cw==

Cibus Inc

CBUS  Earnings Call

Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. It focuses on using gene editing to develop productivity traits in major agricultural crops such as canola, rice, soybean, corn and wheat. The company was founded by Rory Balfour Riggs, Peter Beetham and Greg Gocal in 2001 and is headquartered in San Diego, CA.

Cibus Inc - Ordinary Shares - Class A

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CBUSCibus Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest CBUS News